Similar articles

• Cerebral involvement as the first extracutaneous manifestation of mycosis fungoides.

  de Quintana-Sancho A, Acebo-Mariñas E, Gardeazabal-García J, Aperribay-Esparza A. de Quintana-Sancho A, et al. Actas Dermosifiliogr. 2015 Oct;106(8):693-5. doi: 10.1016/j.ad.2015.02.013. Epub 2015 Jun 10. Actas Dermosifiliogr. 2015. PMID: 26071909 English, Spanish. No abstract available.
• Folliculotropic mycosis fungoides with CD30+ large-cell transformation in a young woman: beneficial effect of bexarotene.

  Mitteldorf C, Stadler R, Bertsch HP, Neumann C. Mitteldorf C, et al. Br J Dermatol. 2007 Mar;156(3):584-6. doi: 10.1111/j.1365-2133.2006.07672.x. Br J Dermatol. 2007. PMID: 17300259 No abstract available.
• [Mycosis fungoides following non-Hodgkin's cutaneous B-cell lymphoma].

  Dereure O, Basset-Seguin N, Guilhou JJ. Dereure O, et al. Ann Dermatol Venereol. 1993;120(9):625-7. Ann Dermatol Venereol. 1993. PMID: 8161118 French.
• The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.

  Spaccarelli N, Rook AH. Spaccarelli N, et al. Dermatol Clin. 2015 Oct;33(4):731-45. doi: 10.1016/j.det.2015.05.008. Epub 2015 Aug 20. Dermatol Clin. 2015. PMID: 26433845 Review.
• Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.

  Shehan JM, Kalaaji AN, Markovic SN, Ahmed I. Shehan JM, et al. J Am Acad Dermatol. 2004 Jul;51(1):103-10. doi: 10.1016/j.jaad.2003.12.028. J Am Acad Dermatol. 2004. PMID: 15243534 Review.